- $358.21bn
- $405.02bn
- $65.01bn
Explainer: How the Merck/Moderna cancer vaccine works and possible barriers to wide use
US lawmakers question Health Secretary Kennedy on vaccine settlement disclosures
Barclays raises Moderna PT on 'transformative' melanoma vaccine potential
US stocks weekly: Rate rattle
US stocks weekly: Rate rattle
Moderna shares whipsaw for third session on cancer vaccine trial data
U.S. STOCKS ON THE MOVE-LSI Industries, SiTime, Andersen Group
Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says (updated)
Brief: Gavi Announces $7 Mln Funding For shipment of 70,000 doses of Ervebo vaccine to DRC
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
Moderna pulls back after massive gains on cancer vaccine trial results
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Moderna $30 bln gain implies many cancer successes
U.S. STOCKS ON THE MOVE-Walmart, Atour Lifestyle, Wolfspeed
Moderna, Merck fall on profit taking after massive gains on cancer vaccine trial results
Street View: Brokerages cheer Moderna, Merck melanoma vaccine trial win
Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says
Chinese vaccine makers jump on news of key success in cancer treatment